Literature DB >> 15287700

Solvent effect on the synthesis of clarithromycin: a molecular dynamics study.

Dilek Duran1, Viktorya Aviyente, Canan Baysa.   

Abstract

Clarithromycin (6-O-methylerythromycin A) is a 14-membered macrolide antibiotic which is active in vitro against clinically important gram-positive and gram-negative bacteria. The selectivity of the methylation of the C-6 OH group is studied on erythromycin A derivatives. To understand the effect of the solvent on the methylation process, detailed molecular dynamics (MD) simulations are performed in pure DMSO, pure THF and DMSO:THF (1:1) mixture by using the anions at the C-6, C-11 and C-12 positions of 2',4"-[O-bis(TMS)]erythromycin A 9-[O-(dimethylthexylsilyl)oxime] under the assumption that the anions are stable on the sub-nanosecond time scale. The conformations of the anions are not affected by the presence of the solvent mixture. The radial distribution functions are computed for the distribution of different solvent molecules around the 'O-' of the anions. At distances shorter than 5 A, DMSO molecules are found to cluster around the C-11 anion, whereas the anion at the C-12 position is surrounded by the THF molecules. The anion at the C-6 position is not blocked by the solvent molecules. The results are consistent with the experimental finding that the methylation yield at the latter position is increased in the presence of a DMSO:THF (1:1) solvent mixture. Thus, the effect of the solvent in enhancing the yield during the synthesis is not by changing the conformational properties of the anions, but rather by creating a suitable environment for methylation at the C-6 position.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287700     DOI: 10.1023/b:jcam.0000030037.67742.cb

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  17 in total

1.  Ab initio prediction of the solution structures and populations of a cyclic pentapeptide in DMSO based on an implicit solvation model.

Authors:  C Baysal; H Meirovitch
Journal:  Biopolymers       Date:  2000-04-15       Impact factor: 2.505

2.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria.

Authors:  F Schlünzen; R Zarivach; J Harms; A Bashan; A Tocilj; R Albrecht; A Yonath; F Franceschi
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

3.  Sensitive liquid chromatography-tandem mass spectrometry method for the determination of clarithromycin in human plasma.

Authors:  G F van Rooyen; M J Smit; A D De Jager; H K L Hundt; K J Swart; A F Hundt
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-03-05       Impact factor: 3.205

4.  A new convenient transformation of erythromycin A into clarithromycin.

Authors:  P Allevi; A Longo; M Anastasia
Journal:  Bioorg Med Chem       Date:  1999-12       Impact factor: 3.641

5.  Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system.

Authors:  P Dauber-Osguthorpe; V A Roberts; D J Osguthorpe; J Wolff; M Genest; A T Hagler
Journal:  Proteins       Date:  1988

Review 6.  Areas, volumes, packing and protein structure.

Authors:  F M Richards
Journal:  Annu Rev Biophys Bioeng       Date:  1977

7.  Acid degradation of erythromycin A and erythromycin B.

Authors:  P Kurath; P H Jones; R S Egan; T J Perun
Journal:  Experientia       Date:  1971-04-15

8.  Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032.

Authors:  S Morimoto; T Nagate; K Sugita; T Ono; K Numata; J Miyachi; Y Misawa; K Yamada; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1990-03       Impact factor: 2.649

9.  Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A.

Authors:  S Morimoto; Y Misawa; T Adachi; T Nagate; Y Watanabe; S Omura
Journal:  J Antibiot (Tokyo)       Date:  1990-03       Impact factor: 2.649

10.  Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin.

Authors:  Y Watanabe; S Morimoto; T Adachi; M Kashimura; T Asaka
Journal:  J Antibiot (Tokyo)       Date:  1993-04       Impact factor: 2.649

View more
  2 in total

1.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

Review 2.  Strategies for discovery and improvement of enzyme function: state of the art and opportunities.

Authors:  Praveen Kaul; Yasuhisa Asano
Journal:  Microb Biotechnol       Date:  2011-08-24       Impact factor: 5.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.